Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/02/1995 | EP0664803A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders |
08/02/1995 | EP0664802A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
08/02/1995 | EP0664801A1 Amide derivatives |
08/02/1995 | EP0664800A1 Novel taxane derivatives, their preparation and pharmaceutical compositions containing them |
08/02/1995 | EP0664794A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
08/02/1995 | EP0664792A1 Fibrinogen receptor antagonists |
08/02/1995 | EP0664789A1 Inhibitors of farnesyl protein transferase |
08/02/1995 | EP0664788A1 Substituted ethanolamine esters |
08/02/1995 | EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
08/02/1995 | EP0664779A1 Antibiotic agents |
08/02/1995 | EP0664709A1 Pharmaceutical composition containing an antimicrobial agent and an antibiotic |
08/02/1995 | EP0664708A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent |
08/02/1995 | EP0664707A1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma. |
08/02/1995 | EP0664706A1 Protein kinase c inhibition and novel compound balanol |
08/02/1995 | EP0664705A1 Use of ergoline derivatives for the treatment of glaucoma |
08/02/1995 | EP0664704A1 Use of dopamine agonists to activate gamma-interferon production |
08/02/1995 | EP0664702A1 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
08/02/1995 | EP0664700A1 Treatment of cachexia and inhibition of il-6 activity |
08/02/1995 | EP0664697A1 Ranitidine chewable tablets |
08/02/1995 | EP0664696A1 Sustained release compositions for treating periodontal disease. |
08/02/1995 | EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
08/02/1995 | EP0569482B1 Synthesis of intermediates in the preparation of acat inhibitors |
08/02/1995 | EP0550615B1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier |
08/02/1995 | EP0544765B1 Piperazinyl derivatives with affinity for 5-HT receptors |
08/02/1995 | EP0522030B1 Hepatitis b vaccine |
08/02/1995 | EP0506774B1 Smoking substitute |
08/02/1995 | EP0386232B1 Nasal administration of benzodiazepine hypnotics |
08/02/1995 | CN1106067A Enzymatic hydroxylation process for the preparation HMG-COA reductase inhibitors and intermediates thereof |
08/02/1995 | CN1106065A Maltose-trehalose converting enzyme, and preparation and uses thereof |
08/02/1995 | CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions |
08/02/1995 | CN1106016A Process of preparing etoposide phosphate and etoposide |
08/02/1995 | CN1106014A PyridoÛ1,2,3-D,EÙÛ1,3,4Ùbenzoxadiazine derivatives |
08/02/1995 | CN1106013A Therapeutic or preventive agents for diseases associated with peroxyli peroxylipid |
08/02/1995 | CN1106009A Preparation of imidazopyridine derivative |
08/02/1995 | CN1106008A 4-aryloxy-and 4-arylthiopiperidine derivatives |
08/02/1995 | CN1106007A Novel sulfonylamino pyrimidines |
08/02/1995 | CN1106006A Crystals of antimicrobial compound |
08/02/1995 | CN1106005A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives |
08/02/1995 | CN1106004A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives |
08/02/1995 | CN1106003A Inhibitors of microsomal triglyceride transfer protein and method |
08/02/1995 | CN1106001A Lactol derivatives, their production and use |
08/02/1995 | CN1105999A Analgesic compounds, their preparation and their use |
08/02/1995 | CN1105998A Naphthoxazines |
08/02/1995 | CN1105996A Preparation of imidazopyridine derivative |
08/02/1995 | CN1105995A Crystal modification of (4-cyclopropyl-6-methyl-pyrimidin-2-yl)-phenyl-amine |
08/02/1995 | CN1105993A Preparation of sustituted azole |
08/02/1995 | CN1105991A Quinoline compounds |
08/02/1995 | CN1105990A Phenylalkanolamine derivatives |
08/02/1995 | CN1105989A Tricyclic 1-aminoethylpyrrol derivative |
08/02/1995 | CN1105988A 1-amino-ethylindole-derivatives |
08/02/1995 | CN1105984A Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
08/02/1995 | CN1105981A 芳香羧酸衍生物 Aromatic carboxylic acid derivatives |
08/02/1995 | CN1105967A Stilbene derivatives and carcinostatics containing them |
08/02/1995 | CN1105882A Parathyroid hormone and raloxifene for increasing bone mass |
08/02/1995 | CN1105867A High-efficacy compound drug for treatment of rheumatism |
08/02/1995 | CN1105859A Stable liquid preparation of complex vitamin for internal use |
08/02/1995 | CN1105858A Pyrimidones and imidazolinones for treatment of shock |
08/02/1995 | CN1105857A Aqueous agent |
08/02/1995 | CN1105856A Smoking suppressant and method of application thereof |
08/02/1995 | CN1105855A Formulation comprising antibacterial substance and antiulcer substance |
08/02/1995 | CN1105854A Use of benzenesulphonylindole derivatives for the preparation of medicines |
08/02/1995 | CN1105853A Methods for inhibiting bone loss |
08/02/1995 | CN1105852A Endermic nutrient material and cosmetic composition containing the same |
08/02/1995 | CN1029405C Lipid A analogs having immunoactivating and antitumor activity |
08/02/1995 | CN1029404C Process for preparation of alpha-adrenergic receptor antagonists |
08/02/1995 | CN1029403C 2-oxo-1-oxa-8-azaspiro|4,5¨ decane derivatives, pharmaceutical compositions containing them and process for preparing-same |
08/02/1995 | CN1029400C Side chain homologe vitamin-D-derivatives, process for preparing same, pharmaceutical preparation containing same and use as medicine |
08/02/1995 | CA2141367A1 Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compounds |
08/02/1995 | CA2141366A1 Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds |
08/02/1995 | CA2141350A1 Novel kojic acid derivatives |
08/01/1995 | US5438151 Reacting N-alpha, N-alpha dimethylated histidine ester salt with halogenothionoformate in presence of base to obtain sulfur containing substituent, protecting, reacting with alkylating agent, freeing by saponification or hydrolysis |
08/01/1995 | US5438144 Controlling damage to peripheral nerves |
08/01/1995 | US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
08/01/1995 | US5438136 Benzo-fused macrocycles promote release of growth hormone |
08/01/1995 | US5438134 Process for the production of unsaturated 17 α-cyanomethyl-17 β-h |
08/01/1995 | US5438118 Peptide mimics having constrained peptide backbone |
08/01/1995 | US5438075 Oral glutamine to reduce stomatitis |
08/01/1995 | US5438074 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
08/01/1995 | US5438073 Dermatological and/or cosmetological composition containing retinoids |
08/01/1995 | US5438072 Taxoid-based compositions |
08/01/1995 | US5438071 Stable porfimer sodium compositions and methods for their manufacture |
08/01/1995 | US5438069 1,2-dideoxy-2-(hydroxymethyl)-1-(methylamino)-myo-inositol hydrochloride and stereoisomers; for treatment of viral infections and metastatic tumors |
08/01/1995 | US5438068 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds |
08/01/1995 | US5438067 Medetomidine preparations for transdermal administration |
08/01/1995 | US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders |
08/01/1995 | US5438060 Method of reducing elevated intraocular pressure |
08/01/1995 | US5438058 Composition intended to be used for retarding hair loss and for inducing and stimulating hair growth, containing 2-alkyl-4-aminopyrimidine (or 2,4-dialkylpyrimidine) 3-oxide derivatives and new compounds derived from 2-alkyl-4-aminopyrimidine 3-oxide |
08/01/1995 | US5438057 Administering a 1,2-bis(3,5-dioxo-4-piperazin-1-yl cyclobutane or-propane for cardioprotection particularly in conjunction with adriamycins |
08/01/1995 | US5438055 Antiarrhythmic benzodiazepines |
08/01/1995 | US5438052 Cephalosporin derivatives |
08/01/1995 | US5438049 16-epiestriol to prevent, inhibit, or reduce inflammation without glycogenic effects |
08/01/1995 | US5438048 Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation |
08/01/1995 | US5437874 Pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredients |
08/01/1995 | US5437873 Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
08/01/1995 | US5437272 Supplying respiratory gas under positive pressure; maintaining respiratory gas exchange in perfluorocarbon liquid-filled pulmonary air passages |
08/01/1995 | CA2141231A1 6-azaindole thromboxane synthase inhibitors |
08/01/1995 | CA2140953A1 Polyhydronorharman synthase inhibitors |
08/01/1995 | CA2020812C Liquid suspensions of nitrofurantoin |
08/01/1995 | CA2018477C Process for preparing 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic, acid monosodium salt trihydrate |
08/01/1995 | CA2000911C Aqueous extract from pittosporaceae effective for diabetes and liver complaints and process for preparing the same |